Inventiva (IVA) Stock Highlights

2.35 | -0.84%

2024-12-21 06:15:08

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the companys operations are in France. Most of the groups revenue is derived from its research partnerships with AbbVie and BI.

Statistics

Range Today

2.29 2.35

Volume Today 2.5K

Range 1 Year

1.53 4.75

Volume 1 Year 17.48M

Range 3 Year

1.53 14.19

Volume 3 Year 35.14M

Range 10 Year

1.53 19.06

Volume 10 Year 51.17M

Highlights

Market Capitalization 223.53M (small)

Floating Shares 13.98M

Current Price 2.35

Price To Earnings -1.25

Price To Revenue 10.81

Earnings Per Share -2.21

Payout Ratio 0%

Performance

Latest -0.84%

1 Month -12.96%

3 Months +14.08%

6 Months -20.88%

1 Year -47.07%

3 Years -82.34%

5 Years -84.47%

10 Years -84.47%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.